HOME >> BIOLOGY >> NEWS
Why do schizophrenics smoke?

ARTICLE: "Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area"

S R Laviolette and D van der Kooy

Neurobiology Research Group, Department of Anatomy & Cell Biology, University of Toronto, Toronto, Canada

Correspondence to: SR Laviolette, Neurobiology Research Group, Department of Anatomy & Cell Biology, 1 King's College Circle, University of Toronto, Toronto, Canada M5S 1A8

Nicotine produces rewarding and aversive motivational effects in humans and other animal species. Here, the authors report that the mammalian ventral tegmental area (VTA) represents a critical neural substrate for the mediation of both the rewarding and aversive properties of nicotine. They demonstrate that direct infusions of nicotine into the VTA can produce both rewarding and aversive motivational effects. While the rewarding effects of higher doses of nicotine were not attenuated by dopamine (DA) receptor blockade, blockade of mesolimbic DA signalling with either systemic or intra-nucleus accumbens (NAc) neuroleptic pretreatment potentiated the sensitivity to nicotine's rewarding properties over a three-order-of-magnitude dose range. Furthermore, the behavioural effects of lower doses of intra-VTA nicotine were reversed, switching the motivational valence of nicotine from aversive to rewarding. These results suggest that blockade of mesolimbic DA signalling induced by neuroleptic medications may block selectively the aversive properties of nicotine, thus increasing the vulnerability to nicotine's rewarding and addictive properties by inducing a unique, drug-vulnerable phenotype.

Citation source: Molecular Psychiatry 2003 Volume 8, number 1, pages 50-59.

For further information on this work, please contact Dr. Steven R. Laviolette, Neurobiology Research Group, Department of Anatomy & Cell Biology, 1 King's College Circle, University of Toronto, Toronto,
'"/>

Contact: Aimee Midei
MolecularPsychiatry@mednet.ucla.edu
310-206-6739
Molecular Psychiatry
13-Feb-2003


Page: 1 2

Related biology news :

1. Genetics, alcohol sensitivity, and behavior
2. Genetics, stress and environmental cues influence relapse drinking
3. Targeted Genetics, M.D. Anderson Cancer Center And University Of Pittsburgh Report Phase I Clinical Trial Results Of Gene Therapy Treatment For Cancer
4. Belgian researchers explore revolutionary approach to angiogenesis
5. Tracing genes, biologists show lizard migration is traced to Florida
6. Certain genes boost fish oils protection against breast cancer
7. Fossil genes reveal how life sheds form and function
8. Missing genes may help explain why plague bacteria are so deadly
9. Do genes respond to global warming?
10. Genetic map of important tree genes outlined
11. Mitochondrial genes cause nuclear mischief

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Why schizophrenics smoke

(Date:4/8/2015)... CHARLOTTE, N.C. , April 8, 2015 /PRNewswire/ ... technology solutions and services, and Morpho, a leading ... in partnership to produce the market,s most advanced ... Infinisource,s iSolved NXG time clock is setting ... attendance and labor data for the small and ...
(Date:4/2/2015)... Germany , April 2, 2015 ... fingerprint tests DERMALOG by far outperforms the strongest ... always maintaining high accuracy, the system is capable ... Hence, the speed proves up to be ten ... faster than its runner-up performance.      ...
(Date:4/2/2015)... 2015 According to preliminary estimates ... somewhat higher than 125 MSEK. This exceeds the guidance ... that revenues for Q1 2015 would be in line ... Q4 2014. The operating result for the first quarter ... interim report will as previously communicated be published on ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2
(Date:4/24/2015)... - Mirego, leader in mobile strategies and solutions, is proud ... extensions for the all new Apple Watch. Made in ... MediaMiser, these extensions will reinvent the way users receive and ... use.  Available today in Canada ... smartwatch that makes for an excellent buddy for business, health ...
(Date:4/24/2015)... , 2015 PAREXEL International Corporation (NASDAQ: ... today announced that Partnerships in Clinical Trials named PAREXEL,s ... 2015 Clinical Innovator of the Year.  The honor recognizes ... the Company,s Perceptive MyTrials ® Data-Driven Monitoring solution. ... during the 2015 Partnership Awards in Boston ...
(Date:4/23/2015)... (PRWEB) April 24, 2015 Ralco announced ... Advanced Birthright Nutrition® (ABN) for the exclusive worldwide rights ... The new technology is a new in-line milk system ... by allowing them to move supplementation milk cups within ... , “This technology lets producers get Birthright™ milk ...
(Date:4/23/2015)... Florida (PRWEB) April 23, 2015 ... it intends to conduct a groundbreaking pilot study ... to be reversed in as little as three ... science of metabolic and nutritional medicine—will aggressively target ... cripple and destroy our aging brain. These include ...
Breaking Biology Technology:Familiprix, OMSignal and MediaMiser apps available today for Apple Watch 2PAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials 2PAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials 3PAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials 4PAREXEL Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials 5Ralco Acquires License to Birthright™ Moveable Milk Cup 2New Study Looks to Reverse Alzheimer’s Disease 2New Study Looks to Reverse Alzheimer’s Disease 3
Cached News: